Trial Profile
Role of Extended-release Niacin on Immune Activation in HIV-infected Patients Treated With Antiretroviral Therapy: a Proof-of-concept Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Niacin (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Proof of concept; Therapeutic Use
- 19 Apr 2018 Status changed from active, no longer recruiting to completed.
- 21 Mar 2017 Planned End Date changed from 1 Nov 2016 to 1 Jun 2017.
- 21 Mar 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Jun 2017.